Evidence map›Paper›PMID 25251366›Full record

ArticlePloS one2014

Directed differentiation of embryonic stem cells using a bead-based combinatorial screening method.

Marina Tarunina, Diana Hernandez, Christopher J Johnson, Stanislav Rybtsov, Vidya Ramathas, Mylvaganam Jeyakumar, Thomas Watson, Lilian Hook, Alexander Medvinsky, Chris Mason and 1 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. From iPSC to manufactured iNK cells using CombiCult® screening platform.Frontiers in cell and developmental biology · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marina TaruninaPlasticell Ltd, Stevenage Bioscience Catalyst, Stevenage, United Kingdom.
Diana HernandezPlasticell Ltd, Stevenage Bioscience Catalyst, Stevenage, United Kingdom; Advanced Centre for Biochemical Engineering, University College London, London, United Kingdom.
Christopher J JohnsonPlasticell Ltd, Stevenage Bioscience Catalyst, Stevenage, United Kingdom.
Stanislav RybtsovMRC Centre for Regenerative Medicine/Institute of Stem cell Research, University of Edinburgh, Edinburgh, United Kingdom.
Vidya RamathasPlasticell Ltd, Stevenage Bioscience Catalyst, Stevenage, United Kingdom.
Mylvaganam JeyakumarPlasticell Ltd, Stevenage Bioscience Catalyst, Stevenage, United Kingdom.
Thomas WatsonPlasticell Ltd, Stevenage Bioscience Catalyst, Stevenage, United Kingdom.
Lilian HookPlasticell Ltd, Stevenage Bioscience Catalyst, Stevenage, United Kingdom.
Alexander MedvinskyMRC Centre for Regenerative Medicine/Institute of Stem cell Research, University of Edinburgh, Edinburgh, United Kingdom.
Chris MasonAdvanced Centre for Biochemical Engineering, University College London, London, United Kingdom.
Yen ChooPlasticell Ltd, Stevenage Bioscience Catalyst, Stevenage, United Kingdom; Progenitor Labs Ltd, Stevenage Bioscience Catalyst, Stevenage, United Kingdom.

Funding

Biotechnology and Biological Sciences Research Council BB/D01347X/1Biotechnology and Biological Sciences Research Council BB/H008780/1Medical Research Council
6 · The paper itself

Abstract

We have developed a rapid, bead-based combinatorial screening method to determine optimal combinations of variables that direct stem cell differentiation to produce known or novel cell types having pre-determined characteristics. Here we describe three experiments comprising stepwise exposure of mouse or human embryonic cells to 10,000 combinations of serum-free differentiation media, through which we discovered multiple novel, efficient and robust protocols to generate a number of specific hematopoietic and neural lineages. We further demonstrate that the technology can be used to optimize existing protocols in order to substitute costly growth factors with bioactive small molecules and/or increase cell yield, and to identify in vitro conditions for the production of rare developmental intermediates such as an embryonic lymphoid progenitor cell that has not previously been reported.

Indexed as

Cell DifferentiationCell LineageAnimalsCell Culture TechniquesCells, CulturedCombinatorial Chemistry TechniquesCulture Media, Serum-FreeDopaminergic NeuronsEmbryonic Stem CellsFlow CytometryHumansImmunohistochemistryImmunophenotypingLymphoid Progenitor CellsMiceMicrospheresCulture Media, Serum-FreeTyrosine 3-Monooxygenase

Identifiers

PMID25251366
PMCPMC4174505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.